• Understanding immune tolerance in solid organ transplantation 

  • Understanding immune tolerance in solid organ transplantation 

  • Understanding immune tolerance in solid organ transplantation 

#Transplant Immunology #Oceania

Live Session:

Wednesday, August 11, 2021 - 8:00 AM (Local time in Sydney)
Local time (Corresponding local time at your current location)

Join us:

Add to your Calendar

Register

TTS Members can register for FREE!

Description:

This masterclass will present the most up-to-date information on immune tolerance in solid organ transplantation, the current evidence, and intervention trials to achieve immune tolerance using the recipients' own T regulatory cells. Recent research on how the immune system may respond to the T and B cell responses after pregnancy will also be discussed.

Learning Objectives:

  • Learn latest advances in novel T regulatory cell therapies to induce tolerance in solid organ transplantation

  • Understand the reasons for acute rejection after pregnancies in solid organ transplant recipients

Accreditation Statement

“This Masterclass has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”

Attendance to the live Masterclass and the completion of the post-event survey are mandatory to receive the certificate and CME credits.

“Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

“Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”

Faculty:

Why pregnancies may increase the risk of acute rejection in solid organ transplant recipients?

Anita Chong

Professor, Section of Transplant
The University of Chicago
Chicago, USA 

Anita Chong received her Ph.D. in cell biology from the Australian National University and is currently a Professor in the Section of Transplant at The University of Chicago, USA. She has a long-standing interest in transplantation immunology, and research efforts in her laboratory focus on immunological tolerance following allogeneic transplantation and the impact of sensitization, as well as on the control of humoral immunity.  Her findings have led to pilot clinical trials for the treatment of antibody-mediated rejection and desensitizing patients for transplantation. 

 

Anita has won numerous awards for her research including the 2015 Basic Science Established Investigator Award from The American Society of Transplantation, 2020 Women Leader in Transplantation Award and the 2020 Distinguished Fellow of the American Association for the Advancement of Science.  She has published 200 research articles, book chapters and reviews, and has received over 50 research awards from the National Institutes of Health, research foundations and industry.  Anita has served on grant review panels and the Advisory Council of the National Institute of Allergy, Immunology and Infectious Diseases at the National Institutes of Health, and on the Advisory Board of Immune Tolerance Network.  She was the Chair of the Basic Science Committee of the Transplantation Society (2010-2016) and is currently the Co-chair of the Community of Transplantation Scientists, American Society of Transplantation, and Chair of Pillar 1 of the Women in Transplantation Initiative.

Regulatory T cell therapies in transplantation

Stephen Alexander

Pediatric Nephrologist
Children’s Hospital at Westmead
Sydney, Australia

Professor Stephen Alexander is a pediatric nephrologist at the Children’s Hospital at Westmead in Sydney Australia. He is a past President of the TSANZ and on IPTA Council. His research interests are in tolerance and genetics in transplantation and kidney disease. His particular interests are in different types of regulatory T cells including modifying T cells by gene editing.  

Schedule (90 min):

  • 05 min

    Welcome and introduction by the Chair

  • 25 min

    Presentation: Why pregnancies may increase the risk of acute rejection in solid organ transplant recipients?, Anita Chong, USA

  • 05 min

    Live Q&A with Anita Chong, USA

  • 25 min

    Presentation: Regulatory T cell therapies in transplantation, Stephen Alexander, Australia

  • 05 min

    Live Q&A with Stephen Alexander, Australia

  • 20 min

    Interactive panel discussion with audience participation led by the Chair

  • 05 min

    Masterclass closing remarks

Join Our Mailing List

Ask a Question

Masterclass Prospectus Request